Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia

被引：1
|
作者：
Wu, Qian
He, Guangsheng
Wu Depei
Sun, Aining
Qiu, Huiying
Jin, Zhengming
Miao, Miao
Tang, XiaoWen
Han, Yue
Shen, Yiming
Chen, Feng
Hu, Xiaohui
Jin, Song
Zhang, Xuhui
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5031.5031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5031
引用
收藏
页数：1
相关论文
共 50 条
  • [21] FLAG-IDA REGIMEN IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOBLASTIC LEUKEMIA: SINGLE-CENTER EXPERIENCE
    Genadieva-Stavrik, G.
    Georgievski, B.
    Cevreska, L.
    Karanfilski, O.
    Pivkova, A.
    Stojanoski, Z.
    Krstevska-Balkanov, S.
    Dukovski, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 560 - 561
  • [22] Reinduction chemotherapy regimen involved decitabine and cladribine improves the prognosis of patients with relapsed or refractory acute myeloid leukemia: A preliminary study
    Hui, Yan
    Li, Yi
    Tong, Xiwen
    Huang, Lifang
    Mao, Xia
    Huang, Liang
    Zhang, Donghua
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (04) : 901 - 908
  • [23] FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies
    Mustafa, Omima
    Abdalla, Khalid
    AlAzmi, Aeshah A.
    Elimam, Naglla
    Abrar, Mohammed Burhan
    Jastaniah, Wasil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1831 - 1838
  • [24] FLAG-liposomal Doxorubicin (Myocet) Regimen for Refractory or Relapsed Acute Leukemia Pediatric Patients
    Quarello, Paola
    Berger, Massimo
    Rivetti, Elisa
    Galletto, Chiara
    Masetti, Riccardo
    Manicone, Rosaria
    Barisone, Elena
    Pession, Andrea
    Fagioli, Franca
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (03) : 208 - 216
  • [25] 10-Day Low Dose Decitabine Regimen for Elderly Acute Myeloid Leukemia Patient Maintenance Treatment
    Liu, Jia
    Kong Peiyan
    Gao, Li
    Zhang, Cheng
    Liu, Yao
    Yan, Hongju
    Zhu, Lidan
    Gao, Shichun
    Lei, Gao
    Zeng, Defu
    Zhang, Xi
    BLOOD, 2018, 132
  • [26] Case report: Combination therapy with selinexor, decitabine and half-dose CAG regimen for relapsed elderly acute myeloid leukemia
    Zhang, Xueya
    Sun, Yuqi
    Zhong, Jinfa
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Etoposide and cytarabine as an effective and safe cytoreductive regimen for relapsed or refractory acute myeloid leukemia
    Nair, G.
    Karmali, R.
    Gregory, S. A.
    Shammo, J. M.
    Fung, H. C.
    Jimenez, A.
    Venugopal, P.
    Larson, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Flag regimen in poor risk acute myeloid leukemia.
    Carella, AM
    Greco, MM
    Cascavilla, N
    D'Arena, G
    Melillo, L
    Sajeva, MR
    Carotenuto, M
    BLOOD, 1999, 94 (10) : 218B - 218B
  • [29] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [30] Decitabine combined with HAAG regimen is an effective salvage treatment for advanced acute myeloid leukemia
    Wei, C.
    Zhengming, J.
    Xiaming, Z.
    Aining, S.
    Huiying, Q.
    Miao, M.
    Cao, J.
    Dandan, G.
    Depei, W.
    Xiaowen, T.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S393 - S393
12345